Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Children's Oncology Group

MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system

(2014) Marco Gessi et al.   NEURO-ONCOLOGY

Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types

(2013) Ed. C. Schwalbe et al.   ACTA NEUROPATHOLOGICA

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

(2012) Regina I. Jakacki et al.   JOURNAL OF CLINICAL ONCOLOGY

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis

(2012) Daniel Picard et al.   LANCET ONCOLOGY

Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy

(2012) Carsten Friedrich et al.   NEURO-ONCOLOGY

The long-term postsurgical prognosis of patients with pineoblastoma

(2011) Matthew Tate et al.   CANCER

Medulloblastoma Comprises Four Distinct Molecular Variants

(2010) Paul A. Northcott et al.   JOURNAL OF CLINICAL ONCOLOGY

Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?

(2009) Swethajit Biswas et al.   PEDIATRIC BLOOD & CANCER

A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET

(2008) Murali Chintagumpala et al.   NEURO-ONCOLOGY